For over 20 years, Boehringer Ingelheim (Canada) Ltd./Ltée has been helping veterinarians and horse owners prevent and treat equine respiratory diseases.
 

The newest addition to our product line, Calvenza, shows our commitment to respiratory disease prevention. Calvenza has been shown to provide protection against both equine influenza (EIV) and equine herpes virus (EHV) and remains the ONLY vaccine in North America to have demonstrated efficacy under severe challenge at 6 and 12 months after vaccination. It’s also the only equine respiratory vaccine in Canada to come with a written guarantee.

Click here to see our Calvenza Guarantee

Ventipulmin^®  remains the only bronchodilator approved for use in horses in Canada for the treatment of acute and chronic airway diseases. Sputolysin^®, a product used to soften and remove respiratory mucus, compliments the use of Ventipulmin^®.

Click here for more details on equine respiratory disease.